50 “Pregnancy is like a crystal ball,” says Sharon HandelmanGotlib. “What happens during those ninemonths is an excellent predictor of women’s long-termhealth outcomes. That makes analyzing the risk of pregnancy complications critical not just for the fetus and the new mother, but for the whole woman, throughout her whole life.” Handelman-Gotlib is one of Israel’s leading figures in fem tech, or technologies that enhance women’s health andwell-being. She is also, as of last year, CEOof Shela (“Hers”), an end-to-end precision-medicine platform for predicting and preventing key pregnancy andpostpartumcomplications, includinggestational diabetes mellitus (GDM), pretermbirth (PTB), and postpartum depression (PPD). Based on the research of microbiome expert Prof. Omry Koren of the Azrieli Faculty of Medicine and data scientist Prof. YoramLouzoun of the Department of Computer Science, and founded together with Dr. Avi Tsur, director of theWomen’s Health Innovation Center at Sheba Hospital and Dr. Adi Eshel, a nutritional expert and postdoctoral student in Koren’s lab, Shela was launched with the help of 949, the healthcare accelerator of Bar-Ilan’s venture builder UnBox. By applying deep learning and Omics technology to large datasets, Shela promises to revolutionize neonatal care, placing advanced real-time, tailored, preventive-medicine tools in the hands of every expectant mother—literally, via a mobile app. Later, in its second stage of development, Shela’s app aims to offer women post-delivery and through to menopause a one-stop-shop for monitoring and improving health across a range of parameters, including nutrition, exercise, and even mental well-being. “Because we’re able to diagnose patients with molecular precision,” explains Handelman-Gotlib, “we can tailor our prenatal and postnatal lifestyle recommendations to their exact health needs. We’re aiming to be a comprehensive, costeffective, and convenient partner for women’s lifelong health journey, and a global leader in the fem tech space.” Another Unbox company poised to disrupt the healthcare industry is Nanocarry Therapeutics, which aims to solve one of modern medicine’s greatest challenges: delivering From Research to Revolutionary Product UnBox Ventures’ Healthcare Accelerator The Nanocarry founding team. From left to right: COO Dr. Oshra Betzer, CEO Revital Mandil Levin, and CSO Prof. Rachela Popovtzer
RkJQdWJsaXNoZXIy NDU2MA==